Related Experiment Videos
Adiponectin: A novel adipokine linking adipocytes and vascular function
Barry J Goldstein1, Rosario Scalia
1Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. barry.goldstein@jefferson.edu
The Journal of Clinical Endocrinology and Metabolism
|June 8, 2004
Summary
Obesity and type 2 diabetes increase cardiovascular risk through mechanisms involving adiposity. Adiponectin, a protein from fat tissue, has anti-inflammatory and anti-atherosclerotic effects beneficial for vascular health.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Metabolic Syndrome
Background:
- Obesity and type 2 diabetes mellitus are major risk factors for cardiovascular disease (CVD) morbidity and mortality.
- Excess adipose tissue contributes to CVD risk through reduced insulin sensitivity and associated metabolic dysfunctions.
- Adipose tissue releases proteins, such as adiponectin, with direct vascular effects.
Purpose of the Study:
- To review recent findings on the vascular actions of adiponectin.
- To complement existing knowledge on adiponectin's role in glucose and lipid metabolism.
- To highlight adiponectin's significance in the adipocyte-insulin-vascular signaling network.
Main Methods:
- Literature review of recent scientific work.
- Synthesis of information on adiponectin's vascular and metabolic effects.
- Focus on the role of adiponectin in cardiovascular risk.
Main Results:
- Adiponectin exhibits potent anti-inflammatory and anti-atherosclerotic properties.
- Adiponectin's vascular actions are linked to its insulin-sensitizing effects.
- Adiponectin is a key component of a signaling network influencing vascular function.
Conclusions:
- Adiponectin plays a crucial role in mitigating cardiovascular risk associated with obesity and type 2 diabetes.
- Understanding adiponectin's vascular effects is vital for managing metabolic and cardiovascular health.
- Adiponectin represents a significant target for therapeutic strategies against obesity-related cardiovascular complications.